Correction to: KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer (Advanced Science, (2021), 8, 20, (2100014), 10.1002/advs.202100014)
Dive into the research topics of 'Correction to: KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer (Advanced Science, (2021), 8, 20, (2100014), 10.1002/advs.202100014)'. Together they form a unique fingerprint.